Southern Acids (M) Berhad Statistics

Total Valuation

Southern Acids (M) Berhad has a market cap or net worth of MYR 410.80 million. The enterprise value is 165.98 million.

Market Cap	410.80M
Enterprise Value	165.98M

Important Dates

The last earnings date was Wednesday, November 27, 2024.

Earnings Date	Nov 27, 2024
Ex-Dividend Date	Oct 17, 2024

Share Statistics

Southern Acids (M) Berhad has 136.93 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	136.93M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	15.16%
Owned by Institutions (%)	11.31%
Float	37.07M

Valuation Ratios

The trailing PE ratio is 24.57.

PE Ratio	24.57
Forward PE	n/a
PS Ratio	0.41
PB Ratio	0.54
P/TBV Ratio	0.54
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 2.32, with an EV/FCF ratio of -5.22.

EV / Earnings	9.93
EV / Sales	0.16
EV / EBITDA	2.32
EV / EBIT	3.67
EV / FCF	-5.22

Financial Position

The company has a current ratio of 5.19, with a Debt / Equity ratio of 0.03.

Current Ratio	5.19
Quick Ratio	4.34
Debt / Equity	0.03
Debt / EBITDA	0.42
Debt / FCF	-0.94
Interest Coverage	42.47

Financial Efficiency

Return on equity (ROE) is 2.99% and return on invested capital (ROIC) is 3.10%.

Return on Equity (ROE)	2.99%
Return on Assets (ROA)	2.77%
Return on Capital (ROIC)	3.10%
Revenue Per Employee	579,682
Profits Per Employee	9,582
Employee Count	1,745
Asset Turnover	1.00
Inventory Turnover	9.51

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -4.43% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-4.43%
50-Day Moving Average	3.14
200-Day Moving Average	3.27
Relative Strength Index (RSI)	31.80
Average Volume (20 Days)	13,290

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Southern Acids (M) Berhad had revenue of MYR 1.01 billion and earned 16.72 million in profits. Earnings per share was 0.12.

Revenue	1.01B
Gross Profit	204.98M
Operating Income	44.68M
Pretax Income	44.23M
Net Income	16.72M
EBITDA	69.00M
EBIT	44.68M
Earnings Per Share (EPS)	0.12

Full Income Statement

Balance Sheet

The company has 369.86 million in cash and 29.82 million in debt, giving a net cash position of 340.04 million or 2.48 per share.

Cash & Cash Equivalents	369.86M
Total Debt	29.82M
Net Cash	340.04M
Net Cash Per Share	2.48
Equity (Book Value)	858.73M
Book Value Per Share	5.58
Working Capital	492.90M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 8.30 million and capital expenditures -40.07 million, giving a free cash flow of -31.78 million.

Operating Cash Flow	8.30M
Capital Expenditures	-40.07M
Free Cash Flow	-31.78M
FCF Per Share	-0.23

Full Cash Flow Statement

Margins

Gross margin is 20.26%, with operating and profit margins of 4.42% and 1.65%.

Gross Margin	20.26%
Operating Margin	4.42%
Pretax Margin	4.37%
Profit Margin	1.65%
EBITDA Margin	6.82%
EBIT Margin	4.42%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 1.67%.

Dividend Per Share	0.05
Dividend Yield	1.67%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	40.95%
Buyback Yield	n/a
Shareholder Yield	1.67%
Earnings Yield	4.07%
FCF Yield	-7.73%

Dividend Details

Stock Splits

The last stock split was on April 6, 1995. It was a forward split with a ratio of 1.25.

Last Split Date	Apr 6, 1995
Split Type	Forward
Split Ratio	1.25

Scores

Southern Acids (M) Berhad has an Altman Z-Score of 4.34.

Altman Z-Score	4.34
Piotroski F-Score	n/a